Muscle Pharm Corporation (MSLPQ)

[fastmoney_2012]

The current secondary offering by MusclePharm took some courage for Mr. Pyatt to stomach. It will ultimately increase outstanding common shares from just less than three million to likely six million fully-diluted shares outstanding. They are effectively trying to sell fifty percent of the company for approximately $12 million. Mr. Pyatt’s pro rata share of the company ownership will be reduced by half. It is a sagacious manager who can realize that it is better to own a smaller piece of something potentially very large versus a bigger part of a capital constrained smaller entity. And big this company may become. With revenue growth consistently in the double-or triple-digit range and 2013 sales likely to exceed $100 million

From the Forbes article